1-5 of 5
Ningyan Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Eph receptors activate myeloid checkpoint receptor LILRB5 to support tumor development

Yubo He, Chengcheng Zhang, Lingxiao Tan, Mi Deng, Xiaoye Liu, Ryan Huang, Xing Yang, Jingjing Xie, Qi Lou, Meng Fang, Caroline Smith, Samuel John, Wei Xiong, Xin Li, Cheryl Lewis, Jade Homsi, Ankit Gupta, Ningyan Zhang, Zhiqiang An, Chengcheng Zhang
Journal: Cancer Immunology Research
Cancer Immunol Res (2025)
https://doi.org/10.1158/2326-6066.CIR-24-0737
Published: 27 March 2025
View articletitled, Eph receptors activate myeloid checkpoint receptor LILRB5 to support tumor development
Open the PDF for Eph receptors activate myeloid checkpoint receptor LILRB5 to support tumor development in another window
Includes: Supplementary data
Journal Articles

Abstract A092: A novel bispecific antibody reprograms the immune suppressive TME and sensitize GBM for immune checkpoint inhibitors

Thomas Wong, Jia-Shiun Leu, Xuejun Fan, Reece Kang, Nourhan Abdelfattah, Fransisca Leonard, Ningyan Zhang, Kyuson Yun
Journal: Cancer Immunology Research
Cancer Immunol Res (2025) 13 (2_Supplement): A092.
https://doi.org/10.1158/2326-6074.IO2025-A092
Published: 23 February 2025
View articletitled, Abstract A092: A novel bispecific antibody reprograms the immune suppressive TME and sensitize GBM for immune checkpoint inhibitors
Journal Articles

Abstract A041: Combined inhibition of S100A4 and TIGIT suppresses late-stage breast cancer metastasis to the lung by activating T and NK cells

Jia-Shiun Leu, Hui Deng, Wei Xiong, Han Nhat Tran, Chihiro Hashimoto, Fransisca Leonard, Thomas Wong, Nourhan Abdelfattah, Zhiqiang An, Ningyan Zhang, Kyuson Yun
Journal: Cancer Immunology Research
Cancer Immunol Res (2025) 13 (2_Supplement): A041.
https://doi.org/10.1158/2326-6074.IO2025-A041
Published: 23 February 2025
View articletitled, Abstract A041: Combined inhibition of S100A4 and TIGIT suppresses late-stage breast cancer metastasis to the lung by activating T and NK cells
Journal Articles

LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development

Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (3): 350–362.
https://doi.org/10.1158/2326-6066.CIR-23-0496
Published: 04 March 2024
View articletitled, LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development
Open the PDF for LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development in another window
Includes: Supplementary data
Journal Articles

Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Xun Gui, Mi Deng, Hao Song, Yuanzhi Chen, Jingjing Xie, Zunling Li, Licai He, Fangfang Huang, Yixiang Xu, Yasuaki Anami, Hai Yu, Chenyi Yu, Leike Li, Zihao Yuan, Xiaoying Xu, Qihui Wang, Yan Chai, Tao Huang, Yi Shi, Kyoji Tsuchikama, X. Charlene Liao, Ningshao Xia, George F. Gao, Ningyan Zhang, Cheng Cheng Zhang, Zhiqiang An
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2019) 7 (8): 1244–1257.
https://doi.org/10.1158/2326-6066.CIR-19-0036
Published: 01 August 2019
View articletitled, Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development
Open the PDF for Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development in another window
Includes: Supplementary data